Also, while patients in the DLG2 cohort have cognitive, behavioral, or psychiatric disorders, remarkably only one out of 29 has an epilepsy phenotype, suggesting this neurodevelopmental phenotype is less often associated with DLG2 deletion. The gene discussed is DLG2; the disease is epilepsy.